Bumrungrad International Hospital
Immunotherapy for breast cancer in Thailand costs from AUD $21,628 / ฿A735,345 to AUD $36,046 / ฿A1,225,575 on average. Final expenses depend on the specific drug protocol, patient weight, and hospital tier. In Australia, this treatment averages AUD $15,428 / ฿A524,546. Patients save approximately 0% by travelling to hubs like Bangkok. Costs usually include specialist consultations, drug administration, and basic follow-up care.
Bookimed Expert Insight: Choosing a major hub like Bangkok provides access to some of the world's most technologically advanced clinics. Bumrungrad International Hospital is a prime example. It is ranked among the top 10 hospitals globally and is accredited by Joint Commission International (JCI). This scale allows for efficient coordination of complex oncology treatments for international patients. While premium hospitals charge more, their high volume and multidisciplinary teams often provide better value for complex cases.
| Thailand | Turkey | ||
| Immunotherapy for breast cancer | from AUD $21,628 / ฿A735,345 | from AUD $13,698 / ฿A465,719 | from AUD $4,037 / ฿A137,264 |
No hidden fees – just official clinic prices. Pay at the clinic for Immunotherapy for breast cancer upon arrival and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Immunotherapy for breast cancer and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Immunotherapy for breast cancer journey.
Immunotherapy in Thailand primarily targets triple-negative breast cancer (TNBC) and HER2-positive subtypes. Patient eligibility depends on clinical staging and protein expression levels like PD-L1. It also depends on the absence of autoimmune conditions. JCI-accredited facilities such as Bumrungrad International Hospital specialise in providing these drug protocols for international patients.
Bookimed Expert Insight: Bumrungrad International Hospital serves over 1,000,000 patients annually. It also maintains Global Healthcare Accreditation for international services. This scale allows them to stock newer biosimilars like Herdara. These local options can help manage the costs of HER2-positive antibody maintenance therapy.
Immunotherapy for breast cancer in Thailand involves infusions every 3 to 6 weeks. The first visit takes 10–14 days for consultations, biomarker testing, and monitoring. Subsequent cycles last 5–7 days. Total treatment generally spans 6 months to 2 years depending on the cancer stage.
Bookimed Expert Insight: Major Bangkok centres like Bumrungrad International Hospital serve over 500,000 international patients annually. They offer telemedicine for follow-up care. Using these remote services allows Australian patients to monitor side effects from home. This reduces the time needed in Thailand for each cycle to just 5 days.
Patient Consensus: Patients suggest bringing full pathology reports and prior imaging. This speeds up the initial assessment in Thailand. Combining your treatment blocks with a medical visa allows for easier multiple entries over 12 months.
JCI-accredited hospitals in Bangkok provide approved immunotherapy drugs for breast cancer. These primarily target triple-negative and HER2-positive subtypes. Key treatments include immune checkpoint inhibitors like Pembrolizumab and Atezolizumab. Doctors also use HER2-targeted therapies such as Trastuzumab and antibody-drug conjugates like Enhertu.
Bookimed Expert Insight: Thailand is one of the few medical hubs producing high-quality domestic biosimilars like Herdara. This makes standard HER2-positive therapy more accessible at major centres like Bumrungrad International Hospital. This facility handles over 1,000,000 patients annually. It also maintains Global Healthcare Accreditation for international surgical care.
Thai hospitals accommodate many international medical tourists seeking breast cancer immunotherapy. Leading centres such as Bumrungrad International Hospital and Bangkok Hospital offer checkpoint inhibitors and molecular testing. These JCI-accredited facilities feature dedicated international wings and English-speaking specialist teams. They also provide streamlined medical visa support for Australian patients.
Bookimed Expert Insight: Thai hospitals like Bumrungrad treat over 1,000,000 patients annually. Half of these are international visitors. This high volume means oncology teams have seen almost every breast cancer subtype. For Australians, this level of experience often exceeds what smaller private clinics offer at home.
Patient Consensus: Patients travelling to Thailand value the hospitality of dedicated international wings. They also appreciate the speed of starting immunotherapy. Many feel like a guest rather than just another patient during intensive treatments.